Mutations in histone modulators are associated with prolonged survival during azacitidine therapy

Early therapeutic decision-making is crucial in patients with higher-risk MDS. We evaluated the impact of clinical parameters and mutational profiles in 134 consecutive patients treated with azacitidine using a combined cohort from Karolinska University Hospital (n=89) and from King's College H...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobiasson, Magnus, McLornan, Donal P., Karimi, Mohsen, Dimitriou, Marios, Jansson, Monika, Azenkoud, Asmaa Ben, Jädersten, Martin, Lindberg, Greger, Abdulkadir, Hani, Kulasekararaj, Austin, Ungerstedt, Johanna, Lennartsson, Andreas, Ekwall, Karl, Mufti, Ghulam J., Hellström-Lindberg, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008347/
https://www.ncbi.nlm.nih.gov/pubmed/26959885
http://dx.doi.org/10.18632/oncotarget.7899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008347/
https://www.ncbi.nlm.nih.gov/pubmed/26959885
http://dx.doi.org/10.18632/oncotarget.7899

Ejemplares similares